
MBBS
VENCLYXTO 10 MG 14 TABLET
How It Works
VENCLYXTO contains the active ingredient venetoclax, which is a selective inhibitor of the B-cell lymphoma-2 (BCL-2) protein. BCL-2 is a protein that helps cancer cells survive by preventing apoptosis (programmed cell death). Venetoclax binds to BCL-2, blocking its function and promoting apoptosis in cancer cells, particularly those with overexpression of BCL-2. This leads to the death of cancer cells and helps to shrink tumors.
Side Effects
- Nausea
- Diarrhea
- Fatigue
- Neutropenia (low white blood cell count)
- Anemia
- Thrombocytopenia (low platelet count)
- Upper respiratory tract infection
Indications
- VENCLYXTO is indicated for the treatment of:
- Chronic lymphocytic leukemia (CLL) in patients who have received at least one prior therapy
- Small lymphocytic lymphoma (SLL) in patients who have received at least one prior therapy
Contraindications
- Hypersensitivity to venetoclax or any component of the formulation
- Concomitant use with strong CYP3A inhibitors or inducers
Price Comparison in Different Countries
Country | Price (per tablet) | Website |
---|---|---|
United States | $200 | GoodRx |
United Kingdom | £150 | NHS |
Australia | AUD 250 | Chemist Warehouse |
Canada | CAD 220 | Canada Drugs Direct |
Germany | €180 | Apotheken Umschau |
Top 5 Global Brands
- AbbVie
- Genentech
- Roche
- Abbott Laboratories
- Merck & Co.
One of the following licensed pharmacy from the nearest location will deliver VENCLYXTO 10 MG 14 TABLET. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.
Questions and Answers
There are no questions yet. Be the first to ask a question about this product.
Reviews
There are no reviews yet.